# Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma

> **NCT00920790** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Adult T-cell Leukemia-lymphoma

## Interventions

- **BIOLOGICAL:** KW-0761

## Key facts

- **NCT ID:** NCT00920790
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-07
- **Final completion:** 2010-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00920790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00920790, "Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00920790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*